Home › Funds › TLS Advisors LLC › OVID

TLS Advisors LLC position in OVID

OVID THERAPEUTICS INC · Health Care

TLS Advisors LLC reported holding 18,858 shares of OVID (OVID THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$51K, representing 0.15% of its reported portfolio and ranking #16 among its reported holdings. TLS Advisors LLC has disclosed OVID holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)18.86K sh
Reported value held$50.73K
Portfolio Weight0.15%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TLS Advisors LLC's OVID position evolved

TLS Advisors LLC first disclosed a stake in OVID in Q3 2023 at 1,319,679 shares (US$5.1M). Across 12 filings, TLS Advisors LLC increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 18,858 shares valued at US$51K. Notable position changes include a 31% trim in Q3 2024 (shares fell 21% over the following quarter), a 97% trim in Q3 2025 (shares rose 25% over the following quarter), a 39% increase in Q1 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.32M $5.07M New
Q4 2023 1.32M $4.25M Hold
Q1 2024 1.32M $4.03M Hold
Q2 2024 1.13M $866.00K Reduce
Q3 2024 771.53K $910.00K Reduce
Q4 2024 680.97K $636.00K Reduce
Q1 2025 680.97K $213.00K Hold
Q2 2025 680.97K $225.00K Hold
Q3 2025 18.86K $26.00K Reduce
Q4 2025 13.60K $374.00K Reduce
Q1 2026 18.86K $41.00K Add
Q2 2026 18.86K $50.73K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OVID and 13F data

OVID (OVID THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in OVID — the largest reported positions include Affinity Asset Advisors, LLC (US$27.3M), ADAR1 Capital Management, LLC (US$20.0M), SILVERARC CAPITAL MANAGEMENT, LLC (US$8.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OVID

All OVID fund holders →

FAQ

How long has TLS Advisors LLC held OVID?

TLS Advisors LLC has disclosed OVID holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TLS Advisors LLC's current position in OVID?

As of Q2 2026, TLS Advisors LLC holds 18.86K shares of OVID (OVID THERAPEUTICS INC), valued at $50.73K, representing 0.15% of its reported portfolio and ranking #16.

Has TLS Advisors LLC been buying or selling OVID?

In the latest 13F filing (Q2 2026), TLS Advisors LLC held unchanged its position in OVID.

Which other funds hold OVID?

Other major institutional holders of OVID include Affinity Asset Advisors, LLC, ADAR1 Capital Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.